Welcome to This Week in Nephrology. This week we're covering 10 notable papers spanning transplantation — from immunosuppression formulations to donor safety and paired exchange innovation — the limits and refinements of drug therapy in chronic kidne…
This week's papers:
1. A Comparative Study of Once-Daily versus Twice-Daily Tacrolimus in Deceased Donor Kidney Transplant Recipients: A National Cohort Analysis. — American Journal of Transplantation 2026
2. Renin-Angiotensin System Inhibition in Dialysis-Dependent Patients with Chronic Heart Failure due to Reduced Ejection Fraction: A Systematic Review and Meta-An… — Nephrology Dialysis Transplantation 2026
3. Comparative Effectiveness and Cardiovascular Safety of Romosozumab versus Teriparatide in Osteoporosis Patients with CKD: Target Trial Emulation Study. — Clinical Journal of the American Society of Nephrology 2026
4. Individualizing pharmacologic and non-pharmacologic therapy for CKD associated with diabetes. — Nephrology Dialysis Transplantation 2026
5. The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials. — Clinical Journal of the American Society of Nephrology 2026
6. Anti-CD38/Anti-CD20 Rescue Therapy for Posttransplant Recurrent FSGS. — Kidney International Reports 2026
7. Long Term Outcomes in Living Kidney Donors Over 30 Years. — Kidney International Reports 2026
8. Key Elements of Clinical Communication After Inpatient Acute Kidney Injury: Modified Delphi Study From the AKINow Recovery Workgroup. — American Journal of Kidney Diseases 2026
9. Integrating Deceased and Living Donation: Six-Year Outcomes of the Italian Deceased-Donor-Initiated Kidney Paired Exchange (DEC-K) Program. — American Journal of Transplantation 2026
10. Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with CKD. — Clinical Journal of the American Society of Nephrology 2026
Listen at https://audioscholar.cc/episode/y54txdbys4
Podden och tillhörande omslagsbild på den här sidan tillhör
AudioScholar. Innehållet i podden är skapat av AudioScholar och inte av,
eller tillsammans med, Poddtoppen.